<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1347" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1347/" /><meta name="ncbi_pagename" content="PROP1-Related Combined Pituitary Hormone Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>PROP1-Related Combined Pituitary Hormone Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="PROP1-Related Combined Pituitary Hormone Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/08/07" /><meta name="citation_author" content="Laura CG de Graaff" /><meta name="citation_pmid" content="20301521" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1347/" /><meta name="citation_keywords" content="PROP1-Related CPHD" /><meta name="citation_keywords" content="PROP1-Related CPHD" /><meta name="citation_keywords" content="Homeobox protein prophet of Pit-1" /><meta name="citation_keywords" content="PROP1" /><meta name="citation_keywords" content="PROP1-Related Combined Pituitary Hormone Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="PROP1-Related Combined Pituitary Hormone Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Laura CG de Graaff" /><meta name="DC.Date" content="2014/08/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1347/" /><meta name="description" content="PROP1-related combined pituitary hormone deficiency (CPHD) is associated with deficiencies of growth hormone (GH); thyroid-stimulating hormone (TSH); the two gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH); prolactin (PrL); and occasionally adrenocorticotropic hormone (ACTH). Most affected individuals are ascertained because of growth failure and failure to thrive starting in infancy or early childhood (approximate age range: 9 months to 8 years). Hypothyroidism is usually mild and occurs in later infancy and childhood. Affected individuals can have absent or delayed and incomplete secondary sexual development with infertility. Untreated males usually have a small penis and small testes. Some females experience menarche, but subsequently require hormone replacement therapy. ACTH deficiency is less common and, when present, usually occurs in adolescence or adulthood." /><meta name="og:title" content="PROP1-Related Combined Pituitary Hormone Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="PROP1-related combined pituitary hormone deficiency (CPHD) is associated with deficiencies of growth hormone (GH); thyroid-stimulating hormone (TSH); the two gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH); prolactin (PrL); and occasionally adrenocorticotropic hormone (ACTH). Most affected individuals are ascertained because of growth failure and failure to thrive starting in infancy or early childhood (approximate age range: 9 months to 8 years). Hypothyroidism is usually mild and occurs in later infancy and childhood. Affected individuals can have absent or delayed and incomplete secondary sexual development with infertility. Untreated males usually have a small penis and small testes. Some females experience menarche, but subsequently require hormone replacement therapy. ACTH deficiency is less common and, when present, usually occurs in adolescence or adulthood." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1347/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/prop1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1347/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE895A07E040BC510000000000960055.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1347_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1347_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/me-ataxia/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/prrt2-parox/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1347_"><span class="title" itemprop="name"><i>PROP1</i>-Related Combined Pituitary Hormone Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: <i>PROP1</i>-Related CPHD</div><p class="contrib-group"><span itemprop="author">Laura CG de Graaff</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1347_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1347_ai__"><div class="contrib half_rhythm"><span itemprop="author">Laura CG de Graaff</span>, MD, PhD<div class="affiliation small">Erasmus Medical Center<br />Rotterdam, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmsumsare@ffaarged.l" class="oemail">ln.cmsumsare@ffaarged.l</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 7, 2000</span>; Last Update: <span itemprop="dateModified">August 7, 2014</span>.</p><p><em>Estimated reading time: 28 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="prop1.Summary" itemprop="description"><h2 id="_prop1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>PROP1</i>-related combined pituitary hormone deficiency (CPHD) is associated with deficiencies of growth hormone (GH); thyroid-stimulating hormone (TSH); the two gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH); prolactin (PrL); and occasionally adrenocorticotropic hormone (ACTH). Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are ascertained because of growth failure and failure to thrive starting in infancy or early childhood (approximate age range: 9 months to 8 years). Hypothyroidism is usually mild and occurs in later infancy and childhood. Affected individuals can have absent or delayed and incomplete secondary sexual development with infertility. Untreated males usually have a small penis and small testes. Some females experience menarche, but subsequently require hormone replacement therapy. ACTH deficiency is less common and, when present, usually occurs in adolescence or adulthood.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Testing for deficient secretion of GH, TSH, LH, FSH, PrL, and ACTH establishes the diagnosis of CPHD. <i>PROP1</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause <i>PROP1</i>-related CPHD.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> GH deficiency is treated with injection of biosynthetic growth hormone from the time of diagnosis until approximately age 17 years. TSH deficiency is treated by thyroid hormone replacement in the form of oral L-thyroxine. In infants with LH and FSAH deficiency micropenis is treated with a limited course of testosterone. Hormone replacement to induce secondary sex characteristics can be initiated in males at age 12 to 13 years with monthly injections of testosterone enanthate and in females at age 11 to 12 years with conjugated estrogens or ethinyl estradiol and later by cycling with estrogen and progesterone. Fertility in both sexes is possible with administration of gonadotropins. ACTH deficiency is treated with oral hydrocortisone.</p><p><i>Surveillance:</i> Regular follow up for all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to monitor for effectiveness and/or complications of hormone replacement therapy and for evidence of other hormone deficiencies.</p><p><i>Evaluation of relatives at risk:</i> For younger sibs: if both (paternal and maternal) <i>PROP1</i> pathogenic variants are known perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to enable early diagnosis and treatment, otherwise monitor growth for evidence of growth failure.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>PROP1</i>-related CPHD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, the sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 25% chance of being affected, a 50% chance of being asymptomatic carriers, and a 25% chance of being unaffected and not carriers. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible when both paternal and maternal <i>PROP1</i> pathogenic variants are known.</p></div></div><div id="prop1.Diagnosis"><h2 id="_prop1_Diagnosis_">Diagnosis</h2><div id="prop1.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of combined pituitary hormone deficiency (CPHD) requires the presence of growth hormone (GH) deficiency and deficiency of at least one of the following other pituitary hormones:</p><ul><li class="half_rhythm"><div>Thyroid-stimulating hormone (TSH)</div></li><li class="half_rhythm"><div>The two gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH)</div></li><li class="half_rhythm"><div>Prolactin (PrL)</div></li><li class="half_rhythm"><div>Less frequently, adrenocorticotropic hormone (ACTH)</div></li></ul><p>The diagnosis of <i>PROP1</i>-related combined pituitary hormone deficiency, the focus of this <i>GeneReview</i>, requires the diagnosis of CPHD and identification of at least one <i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Growth hormone (GH) deficiency</b> is suspected in children with:</p><ul><li class="half_rhythm"><div>Neonatal hypoglycemia; AND/OR</div></li><li class="half_rhythm"><div>Proportionate short stature and delayed bone maturation (in the absence of an inherited bone dysplasia or chronic disease) with the following growth patterns [<a class="bk_pop" href="#prop1.REF.rosenfeld.1996">Rosenfeld 1996</a>]:</div><ul><li class="half_rhythm"><div>Severe short stature with height more than three standard deviations (SD) below the mean for age; OR</div></li><li class="half_rhythm"><div>Moderate short stature with height 2-3 SD below the mean for age and growth deceleration with height velocity less than 25th percentile for age; OR</div></li><li class="half_rhythm"><div>Severe growth deceleration with height velocity less than fifth percentile for age</div></li></ul></li></ul><p><b>Thyroid-stimulating hormone (TSH) deficiency</b> is suspected in the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Infants over age one month with large posterior fontanelle (diameter &#x0003e;1 cm), jaundice that lasts for more than one week after birth, macroglossia, hoarse cry, distended abdomen, umbilical hernia, excessive sleeping, and hypotonia</div><div class="half_rhythm">Note: Infants with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypothyroidism may show no signs in the first month of life.</div></li><li class="half_rhythm"><div class="half_rhythm">Children with growth failure, poor weight gain, and delayed bone maturation</div></li></ul><p><b>Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiency</b> is suspected in the following:</p><ul><li class="half_rhythm"><div>Newborn males with micropenis (stretched penile length &#x0003c;2.5 cm in a term infant) without hypospadias, with or without cryptorchidism</div></li><li class="half_rhythm"><div>Adolescent males with onset of puberty after age 14 years or cessation of secondary sexual development</div></li><li class="half_rhythm"><div>Adolescent females with lack of breast development or menses by age 14 years</div></li></ul><p><b>Prolactin (PrL) deficiency</b> is suspected in females with impaired lactation.</p><p><b>Adrenocorticotropic hormone (ACTH) deficiency</b> is suspected in children and adults with persistent weakness, fever, abdominal pain, anorexia, and weight loss. Signs of acute ACTH deficiency include acute hypotension, dehydration, and shock accompanied by hyponatremia, hyperkalemia, and hypoglycemia.</p></div><div id="prop1.Testing"><h3>Testing</h3><p>Testing concomitantly for deficient secretion of GH, TSH, LH, FSH, PrL, and ACTH should be performed for diagnosis and management [<a class="bk_pop" href="#prop1.REF.phillips.1995">Phillips 1995</a>, <a class="bk_pop" href="#prop1.REF.rimoin.1997">Rimoin &#x00026; Phillips 1997</a>].</p><p>Deficiencies of all pituitary hormones may be assessed simultaneously using a triple test comprising the following:</p><ul><li class="half_rhythm"><div>Insulin-induced hypoglycemia (with a blood sugar &#x0003c;40 mg/dL or half the baseline value), which should increase the serum concentration of growth hormone, prolactin, and cortisol</div></li><li class="half_rhythm"><div>TRH (thyrotropin-releasing hormone), which should increase serum concentrations of TSH and PrL</div></li><li class="half_rhythm"><div>Exogenous GnRH (gonadotropin-releasing hormone), which should increase serum concentrations of LH and FSH</div></li></ul><p><b>Growth hormone (GH) deficiency.</b> Note: (1) Even in the appropriate clinical setting, the diagnosis of GH deficiency remains problematic because of the difficulty in measuring physiologic GH secretion. (2) Provocative tests of GH secretion are widely used in the diagnosis of GH deficiency, although they are associated with a high false positive rate.</p><p>Stimuli used for provocative testing for GH deficiency include exercise, arginine, L-dopa, clonidine, insulin, insulin-arginine, glucagon, and propranolol.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Confirmatory finding.</b> Serum concentration of GH less than 7-10 ng/dL on two provocative tests</div><div class="half_rhythm">Note: A peak serum concentration of GH greater than 7-10 ng/mL on one test rules out the diagnosis of GH deficiency.</div></li></ul><p><b>Thyroid-stimulating hormone (TSH) deficiency</b></p><ul><li class="half_rhythm"><div><b>Suggestive finding.</b> Serum T<sub>4</sub> concentration 1.0 &#x000b5;g/dL below normal for age with a low serum TSH concentration (normal: 0.1 mU/L to 4.5-5.5 mU/L)</div></li><li class="half_rhythm"><div><b>Confirmatory finding.</b> Subnormal increase in serum concentration of TSH 30 minutes after infusion of TRH</div></li></ul><p>Note: All <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypothyroidism screen for elevated TSH. Persons with central hypothyroidism normally have low thyroid hormone concentrations associated with inappropriately low/normal TSH levels. Note: In countries in which the neonatal screening program is based on TSH levels only, such individuals are not detected.</p><p><b>Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiency</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Suggestive finding.</b> Low serum concentrations of LH and FSH and low serum testosterone concentration in males; low serum estradiol concentration (and/or the lack of progestin-induced withdrawal bleeding) in females age 14 years or older</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Confirmatory finding.</b> Subnormal increase in serum concentration of LH and FSH following infusion of GnRH in an individual age 14 years or older</div><div class="half_rhythm">Note: No absolute cutoff values have been established.</div></li></ul><p><b>Prolactin (PrL) deficiency</b></p><ul><li class="half_rhythm"><div><b>Suggestive finding.</b> Very low or undetectable baseline prolactin</div></li><li class="half_rhythm"><div><b>Confirmatory finding.</b> Absent response to TRH stimulation</div></li></ul><p><b>Adrenocorticotropic hormone (ACTH) deficiency</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Suggestive findings</b></div><ul><li class="half_rhythm"><div class="half_rhythm">Low serum concentration of sodium and glucose and elevated serum concentration of potassium in an acutely ill individual</div></li><li class="half_rhythm"><div class="half_rhythm">Serum ACTH concentration that is inappropriately low in the face of a low serum concentration of cortisol</div><div class="half_rhythm">Note: Blood sample for the ACTH assay needs to be collected properly and processed rapidly.</div></li><li class="half_rhythm"><div class="half_rhythm">Normal renin-aldosterone axis</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Confirmatory finding.</b> Subnormal increase in serum ACTH concentration in response to CRH (corticotropin releasing hormone), suggesting a pituitary etiology of ACTH deficiency.</div><div class="half_rhythm">Note: Insulin-induced hypoglycemia may also be used, but a subnormal response could indicate a hypothalamic or a pituitary cause.</div></li></ul><div id="prop1.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>PROP1</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause <i>PROP1</i>-related CPHD.</p><div id="prop1.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>PROP1</i>-Related Combined Pituitary Hormone Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1347/table/prop1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prop1.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PROP1</i></td><td headers="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2,&#x000a0;3</sup></td><td headers="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;98%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_prop1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="prop1.TF.1.1"><p class="no_margin">See <a href="/books/NBK1347/#prop1.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#prop1.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="prop1.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="prop1.TF.1.3"><p class="no_margin">The common recurring <i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in which three AG repeats are reduced to two AG repeats (c.301_302delAG) accounts for 55% of alleles in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases and 12% of alleles in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases of CPHD (i.e., single occurrence in a family).</p></div></dd><dt>4. </dt><dd><div id="prop1.TF.1.4"><p class="no_margin">The proportion of CPHD caused by pathogenic variants in <i>PROP1</i> varies by study suggesting either bias in ascertainment in some studies or variation in the frequency of <i>PROP1</i> pathogenic variants between populations of different ethnic origins [reviewed in <a class="bk_pop" href="#prop1.REF.de_graaff.2010.363">de Graaff et al 2010</a>]. See <a class="figpopup" href="/books/NBK1347/table/prop1.T.prop1_pathogenic_variant_detecti/?report=objectonly" target="object" rid-figpopup="figprop1Tprop1pathogenicvariantdetecti" rid-ob="figobprop1Tprop1pathogenicvariantdetecti">Table 2</a>.</p></div></dd><dt>5. </dt><dd><div id="prop1.TF.1.5"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>6. </dt><dd><div id="prop1.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#prop1.REF.abr_o.2006.294">Abr&#x000e3;o et al [2006]</a> reported complete <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>PROP1</i> in two sibs with GH deficiency associated with other pituitary hormone deficiencies (TSH, PRL and gonadotropins). One of the sibs also had an evolving cortisol deficiency. <a class="bk_pop" href="#prop1.REF.kelberman.2009.96">Kelberman et al [2009]</a> identified a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> deletion of <i>PROP1</i> in two individuals with CPHD born to <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents. <a class="bk_pop" href="#prop1.REF.zhang.2010.98">Zhang et al [2010]</a> reported in two pedigrees with CPHD a deletion of a segment of about 53.2 kb encompassing <i>PROP1</i> and adjacent sequences.</p></div></dd></dl></div></div></div></div></div><div id="prop1.Testing_Strategy_To_ConfirmEstabli"><h3>Testing Strategy To Confirm/Establish the Diagnosis in a Proband</h3><p>Growth hormone (GH) deficiency must be present.</p><p>The order in which TSH, LH, FSH, PrL, and ACTH secretion is assessed depends on the findings in the individual.</p><p><b>Molecular genetic testing</b></p><ul><li class="half_rhythm"><div class="half_rhythm">In individuals with GH deficiency and at least one other pituitary hormone deficiency, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>PROP1</i> (first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no or only one <i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified) is indicated to establish the diagnosis of <i>PROP1</i>-related CPHD.</div><div class="half_rhythm">The likelihood of CPHD being <i>PROP1</i>-related CPHD varies by study suggesting either bias in ascertainment in some studies or variation in the frequency of <i>PROP1</i> pathogenic variants between populations of different ethnic origins. In several international centers (UK, India, and Poland), <i>PROP1</i> pathogenic variants were identified in almost 30% of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases and only 1%-2% of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases [<a class="bk_pop" href="#prop1.REF.turton.2005.10">Turton et al 2005</a>]. <a class="figpopup" href="/books/NBK1347/table/prop1.T.prop1_pathogenic_variant_detecti/?report=objectonly" target="object" rid-figpopup="figprop1Tprop1pathogenicvariantdetecti" rid-ob="figobprop1Tprop1pathogenicvariantdetecti">Table 2</a> summarizes the <i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> frequencies in persons with CPHD from several published articles.</div></li><li class="half_rhythm"><div class="half_rhythm">For individuals with CPHD in whom no <i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, consider testing other genes in which pathogenic variants are known to cause CPHD. Use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> may be appropriate (see <a href="#prop1.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="prop1.T.prop1_pathogenic_variant_detecti" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>PROP1</i> Pathogenic Variant Detection Frequency in Cohorts with CPHD</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1347/table/prop1.T.prop1_pathogenic_variant_detecti/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prop1.T.prop1_pathogenic_variant_detecti_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th><th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simplex / Familial Cases</th><th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N Patients</th><th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N Families</th><th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N Pathogenic Variants / N Tested</th><th id="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Origin</th></tr></thead><tbody><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.dateki.2010.4043">Dateki et al [2010]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">71</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Japanese</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.diaczok.2008.4351">Diaczok et al [2008]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.de_graaff.2010.363">De Graaff et al [2010]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mostly <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">78</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">76</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dutch</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.mclennan.2003.785">McLennan et al [2003]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simplex</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Australian</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.kim.2003.277">Kim et al [2003]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Simplex</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Korean</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.rainbow.2005.163">Rainbow et al [2005]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mostly <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">26</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">UK</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.fernandezrodriguez.2011.181">Fernandez-Rodriguez et al [2011]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/23</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spanish</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.turton.2005.10">Turton et al [2005]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">153</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Various</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.osorio.2002.5076">Osorio et al [2002]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mostly <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">76</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">74</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/43</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brazilian</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.navardauskaite.2014.299">Navardauskaite et al [2014]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">67</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA<sup>1</sup></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">47/67</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lithuania</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.nystr_m.2011.208">Nystr&#x000f6;m et al [2011]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/17</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.reynaud.2006.3329">Reynaud et al [2006]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">195</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">165</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/109</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Various</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.lebl.2005.389">Lebl et al [2005]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mostly <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">74</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA&#x000a0;<sup>2</sup></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/74</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Czech</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.zimmermann.2007.587">Zimmermann et al [2007]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/17</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.vieira.2007.1097">Vieira et al [2007]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">40</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">36</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/26</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brazilian</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.vallettekasic.2001.4529">Vallette-Kasic et al [2001]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mostly <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/23&#x000a0;<sup>3</sup></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Various</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.lemos.2006.479">Lemos et al [2006]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">46</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Portuguese</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.hal_sz.2006.255">Hal&#x000e1;sz et al [2006]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/35</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hungarian</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.delado_y.1999.1645">Delado&#x000eb;y et al [1999]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">73</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">36</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35/73&#x000a0;<sup>3</sup></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prop1.REF.fofanova.1998.45">Fofanova et al [1998]</a></td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mixed</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/14</td><td headers="hd_h_prop1.T.prop1_pathogenic_variant_detecti_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Russian</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> frequencies reported in CPHD populations (Studies that investigated cohorts mixed <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> growth hormone deficiency (IGHD) and CPHD are not included.)</p></div></dd><dt>1. </dt><dd><div id="prop1.TF.2.1"><p class="no_margin">67 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, including nine sib pairs and two sib triplets</p></div></dd><dt>2. </dt><dd><div id="prop1.TF.2.2"><p class="no_margin">Including 4 sib pairs</p></div></dd><dt>3. </dt><dd><div id="prop1.TF.2.3"><p class="no_margin">Same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in more than one individual from a given family</p></div></dd><dt>4. </dt><dd><div id="prop1.TF.2.4"><p class="no_margin">17 <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases from seven families; 29 <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases</p></div></dd><dt>5. </dt><dd><div id="prop1.TF.2.5"><p class="no_margin">Seven <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases from four families; seven <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases</p></div></dd></dl></div></div></div></div></div><div id="prop1.Clinical_Characteristics"><h2 id="_prop1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="prop1.Clinical_Description"><h3>Clinical Description</h3><p><i>PROP1</i> pathogenic variants are associated with deficiencies of growth hormone (GH), thyroid-stimulating hormone (TSH), gonadotropins (FSH and LH), prolactin (PrL), and adrenocorticotropic hormone (ACTH). The secretion of all these pituitary-derived hormones declines gradually with age; often the order of appearance of hormone deficiency is GH, LH and FSH, TSH, and ACTH.</p><p>The degree of hormone deficiency and the age of onset of the deficiency are variable even within the same family. In a follow-up study of nine individuals with <i>PROP1</i> pathogenic variants, all seven who had reached the age of puberty required sex hormone replacement therapy (HRT). Repeated testing of pituitary function indicated a decline over time; all individuals developed some degree of adrenal insufficiency [<a class="bk_pop" href="#prop1.REF.b_ttner.2004.5256">B&#x000f6;ttner et al 2004</a>].</p><p><b>GH deficiency</b>. Children with <i>PROP1</i>-related CPHD are often ascertained because of short stature. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children have normal birth weight and birth length and an uncomplicated perinatal period. Growth failure and failure to thrive begin in infancy or early childhood (range: ~9 months to ~8 years).</p><p>Individuals with <i>PROP1</i>-related CPHD who have untreated growth hormone deficiency have proportional short stature (i.e., &#x0003c;4 cm difference between length of arm span and height) with proportionately small hands and feet. Height is usually profoundly reduced, with SD scores of more than -3.7 [<a class="bk_pop" href="#prop1.REF.b_ttner.2004.5256">B&#x000f6;ttner et al 2004</a>, <a class="bk_pop" href="#prop1.REF.reynaud.2004.5779">Reynaud et al 2004</a>].</p><p>In newborn infants, the primary manifestation may be hypoglycemia.</p><p><b>TSH deficiency.</b> Rarely, hypothyroidism is the presenting finding [<a class="bk_pop" href="#prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck et al 1998</a>]. Hypothyroidism is usually mild and occurs in later infancy and childhood. Since it is usually not <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or severe, it is not associated with intellectual disability.</p><p><b>FSH and LH deficiency.</b> Affected individuals can have absent or delayed and incomplete secondary sexual development with infertility.</p><ul><li class="half_rhythm"><div>Untreated males usually have a small penis and small testes.</div></li><li class="half_rhythm"><div>Some females experience menarche before requiring hormone replacement therapy [<a class="bk_pop" href="#prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck et al 1998</a>].</div></li></ul><p>In some individuals, apparently <a href="/books/n/gene/kms/">isolated gonadotropin deficiency</a> may be the presenting finding: in one family two brothers were thought to have <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hypogonadotropic hypogonadism until they developed GH deficiency and TSH deficiency after age 30 years; at that time CPHD was diagnosed [<a class="bk_pop" href="#prop1.REF.reynaud.2005.4880">Reynaud et al 2005</a>].</p><p><b>PrL deficiency.</b> Prolactin deficiency generally causes few symptoms, as prolactin is only required at the time of breastfeeding.</p><p><b>ACTH deficiency.</b> It was initially thought that ACTH deficiency was uncommon and, when present, usually occurred in adolescence or adulthood; however, longer follow up has shown that some degree of adrenal failure may occur in most individuals with <i>PROP1</i> pathogenic variants [<a class="bk_pop" href="#prop1.REF.b_ttner.2004.5256">B&#x000f6;ttner et al 2004</a>].</p><p><b>CPHD</b>. Severe deficiency of GH and insulin-like growth factor 1 (IGF-1), especially when combined with hypothyroidism and absence of secondary sexual development, are associated with significant growth failure. In one Brazilian family in which eight individuals had this combination of findings; adult heights ranged from 5.9 to 9.6 SD below the mean [<a class="bk_pop" href="#prop1.REF.pernasetti.2000.390">Pernasetti et al 2000</a>].</p><p><b>Other findings</b></p><ul><li class="half_rhythm"><div>An 8&#x000b0; to 20&#x000b0; limitation of extension of the elbows that increases with age has been observed.</div></li><li class="half_rhythm"><div>Facies are characterized as "immature," with a depressed nasal bridge and relative decrease in the vertical dimensions of the face [<a class="bk_pop" href="#prop1.REF.pirinen.1994.144">Pirinen et al 1994</a>].</div></li><li class="half_rhythm"><div>Obesity, rare in childhood, is more common in adulthood.</div></li><li class="half_rhythm"><div>Intelligence is usually normal.</div></li></ul><p><b>Imaging studies.</b> The pituitary may initially appear diffusely enlarged in childhood and then reduced in size in adolescence or adulthood [<a class="bk_pop" href="#prop1.REF.mendonca.1999.942">Mendonca et al 1999</a>, <a class="bk_pop" href="#prop1.REF.riepe.2001.4353">Riepe et al 2001</a>, <a class="bk_pop" href="#prop1.REF.reynaud.2004.5779">Reynaud et al 2004</a>, <a class="bk_pop" href="#prop1.REF.tatsumi.2004.635">Tatsumi et al 2004</a>, <a class="bk_pop" href="#prop1.REF.voutetakis.2004a.2200">Voutetakis et al 2004a</a>, <a class="bk_pop" href="#prop1.REF.voutetakis.2004b.257">Voutetakis et al 2004b</a>].</p><p>The sella turcica may be normal in size or enlarged, or may appear "empty."</p></div><div id="prop1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No correlation has been observed between the different <i>PROP1</i> pathogenic variants and the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual.</p></div><div id="prop1.Penetrance"><h3>Penetrance</h3><p>The clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>PROP1</i>-related CPHD is variable, even among individuals with the same pathogenic variants. Variation is observed in the age at diagnosis and the severity of findings resulting from deficiencies of GH, TSH, LH, FSH, and PrL [<a class="bk_pop" href="#prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck et al 1998</a>].</p><p>Anterior pituitary function including adrenal function can deteriorate over time such that <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is age dependent.</p></div><div id="prop1.Prevalence"><h3>Prevalence</h3><p>The frequency of pituitary dwarfism is estimated at 1:4000 in England and the US. The proportion of individuals with pituitary dwarfism who have CPHD ranges from 43% to 63%, suggesting a frequency of approximately 1:8000 for CPHD.</p></div></div><div id="prop1.Genetically_Related_Allelic_Disord"><h2 id="_prop1_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>PROP1.</i></p></div><div id="prop1.Differential_Diagnosis"><h2 id="_prop1_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="http://omim.org/phenotypicSeries/PS613038" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Pituitary Hormone Deficiency, Combined: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p><p>While short stature, delayed growth velocity, and delayed skeletal maturation are all seen with GH deficiency, none of these manifestations is specific for GH deficiency; therefore, individuals with these findings should be evaluated for other, systemic diseases associated with short stature before doing provocative tests to document GH deficiency.</p><div id="prop1.Combined_Pituitary_Hormone_Deficie"><h3>Combined Pituitary Hormone Deficiencies (CPHD)</h3><p>Whereas many individuals with pituitary dwarfism have a craniopharyngioma or other non-genetic cause, 7% to 12% of individuals have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a>, suggesting that many cases are the result of genetic factors [<a class="bk_pop" href="#prop1.REF.phillips.1995">Phillips 1995</a>].</p><p>Familial CPHD can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> manner. To date, <i>PROP1</i>, <i>POU1F1</i> (formerly <i>PIT1</i>), <i>HESX1</i>, <i>LHX3</i>, and <i>LHX4</i> have been associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> CPHD [<a class="bk_pop" href="#prop1.REF.dattani.1998.125">Dattani et al 1998</a>, <a class="bk_pop" href="#prop1.REF.dattani.2003">Dattani 2003</a>, <a class="bk_pop" href="#prop1.REF.kim.2003.277">Kim et al 2003</a>, <a class="bk_pop" href="#prop1.REF.mclennan.2003.785">McLennan et al 2003</a>, <a class="bk_pop" href="#prop1.REF.reynaud.2004.5779">Reynaud et al 2004</a>].</p><p>Although genetic alterations of a specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are associated with a "typical" <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, variability in the onset and extent of clinical manifestations can be observed. Depending on the gene involved, pituitary manifestations may range from normal pituitary function to complete pan hypopituitarism and from normal height to severe growth retardation.</p><p>For the clinician this means that continuous monitoring of the hormonal state of the patient until adulthood is mandatory to avoid late-onset complications. For the geneticist it means that the type of hormone deficiencies, the extra-pituitary manifestations and the family history give valuable information for a specific genetic workup, but that additional "atypical" genes have to be considered if the initial analysis fails to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the "first-choice" candidate genes [<a class="bk_pop" href="#prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle &#x00026; Klammt 2011</a>].</p><p><b><i>PROP1.</i></b>
<a class="bk_pop" href="#prop1.REF.b_ttner.2004.5256">B&#x000f6;ttner et al [2004]</a> concluded that 50% of CPHD has a genetic basis and that half of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases are caused by <i>PROP1</i> pathogenic variants; however, more recent data demonstrate that this is not the situation for <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (see <a class="figpopup" href="/books/NBK1347/table/prop1.T.prop1_pathogenic_variant_detecti/?report=objectonly" target="object" rid-figpopup="figprop1Tprop1pathogenicvariantdetecti" rid-ob="figobprop1Tprop1pathogenicvariantdetecti">Table 2</a>).</p><p><b><i>POU1F1</i> (formerly <i>PIT1</i>).</b> Pathogenic variants of <i>POU1F1</i> causing CPHD can be inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><i>POU1F1</i> variants are associated with deficiencies of growth hormone and prolactin and variable deficiency of the &#x003b2; subunit of TSH. Of note, <i>POU1F1</i> variants are also associated with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> growth hormone deficiency [<a class="bk_pop" href="#prop1.REF.dattani.2003">Dattani 2003</a>].</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal birth weight and birth length and an uncomplicated perinatal course. Growth hormone deficiency is usually severe and most individuals have growth failure in early infancy.</p><p>Hypothyroidism can be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, or mild and later in onset; progressive loss of TSH occurs over time.</p><p>Affected individuals have proportional short stature and distinctive facies characterized by prominent forehead, marked midface hypoplasia with depressed nasal bridge, deep-set eyes, and short nose with anteverted nostrils [<a class="bk_pop" href="#prop1.REF.aarskog.1997.829">Aarskog et al 1997</a>].</p><p>The pituitary usually appears hypoplastic on imaging studies.</p><p>For more information about specific <i>POU1F1</i> variants, click <a href="/books/NBK1347/bin/prop1-POU1F1_variants.pdf">here</a>.</p><p><b><i>HESX1.</i></b> Pathogenic variants in <i>HESX1</i> have been identified with both <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance of CPHD [<a class="bk_pop" href="#prop1.REF.cohen.2003.4832">Cohen et al 2003</a>], sometimes combined with septooptic dysplasia (SOD). Affected individuals may present with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> growth hormone deficiency (IGHD) [<a class="bk_pop" href="#prop1.REF.vivenza.2011.705">Vivenza et al 2011</a>].</p><p>Affected individuals have midline defects, optic nerve hypoplasia, neuro-pituitary ectopia, and pituitary hypoplasia associated with hormonal deficiencies [<a class="bk_pop" href="#prop1.REF.mcnay.2007.691">McNay et al 2007</a>].</p><p><i>HESX1</i> is expressed in the thickened layer of oral ectoderm that gives rise to the Rathke pouch, the primordium of the anterior pituitary. Downregulation of <i>HESX1</i> coincides with the differentiation of pituitary-specific cell types.</p><p>For information on specific <i>HESX1</i> variants, click <a href="/books/NBK1347/bin/prop1-HESX1_variants.pdf">here</a>.</p><p><b><i>LHX3</i> and <i>LHX4.</i></b> LHX3 and LHX4 are members of the LIM-homeodomain family of transcription factors. Together, they regulate proliferation and differentiation of pituitary-specific cell lineages.</p><p><b><i>LHX3,</i></b> comprising seven coding exons and six introns that span 8.7 kilobases, is located in the subtelomeric region of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 9. Several <i>LHX3</i> variants have been described to date. For a comprehensive review, see <a class="bk_pop" href="#prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle &#x00026; Klammt [2011]</a></p><p>For information on specific <i>LHX3</i> variants, click <a href="/books/NBK1347/bin/prop1-LHX3_variants.pdf">here</a>.</p><p><b><i>LHX4</i></b> extends over approximately 45 kb on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1. Heterozygous variants in <i>LHX4</i> are associated with CPHD along with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> defects in the cerebellum and sella turcica. Several <i>LHX4</i> variants have been described to date. For a comprehensive review, see <a class="bk_pop" href="#prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle &#x00026; Klammt [2011]</a>.</p><p>For information on specific <i>LHX4</i> variants, click <a href="/books/NBK1347/bin/prop1-LHX4_variants.pdf">here</a>.</p></div><div id="prop1.Isolated_Growth_Hormone_Deficiency"><h3>Isolated Growth Hormone Deficiency</h3><p>CPHD needs to be differentiated from <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> growth hormone deficiency (IGHD).</p><p><b><i>GH1-</i>related IGHD</b></p><ul><li class="half_rhythm"><div>IGHD IA and IB are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</div><ul><li class="half_rhythm"><div>In IGHD 1A, <i>GH1</i> deletions, frameshifts, and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants lead to GH deficiency with severe growth failure; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals often develop anti-GH antibodies when given exogenous GH.</div></li><li class="half_rhythm"><div>In IGHD IB, <i>GH1</i> <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants are responsible for low (but detectable) levels of GH. Growth failure is less severe than in IGHD IA, and individuals usually respond well to exogenous GH.</div></li></ul></li><li class="half_rhythm"><div>IGHD II is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Splice site or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>GH1</i> variants have a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect. The clinical severity of IGHD II varies across kindreds. Affected individuals usually respond well to exogenous GH.</div></li></ul></div><div id="prop1.Isolated_Hypogonadotropic_Hypogona"><h3>Isolated Hypogonadotropic Hypogonadism</h3><p>In one family two brothers with <i>PROP1</i>-related CPHD were thought to have <a href="/books/n/gene/kms/">hypogonadotropic hypogonadism</a> until they developed GH deficiency and TSH deficiency after age 30 years [<a class="bk_pop" href="#prop1.REF.reynaud.2005.4880">Reynaud et al 2005</a>]. Their findings demonstrate that <i>PROP1</i> variants should also be considered among possible genetic causes of apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> hypogonadotropic hypogonadism.</p></div><div id="prop1.Syndromes_that_Include_Hypopituita"><h3>Syndromes that Include Hypopituitarism</h3><p>Variants in the following genes have been studied in syndromes that include hypopituitarism [<a class="bk_pop" href="#prop1.REF.roessler.2003.13424">Roessler et al 2003</a>, <a class="bk_pop" href="#prop1.REF.kelberman.2007.s3">Kelberman &#x00026; Dattani 2007</a>, <a class="bk_pop" href="#prop1.REF.ashkenazihoffnung.2010.721">Ashkenazi-Hoffnung et al 2010</a>]:</p><ul><li class="half_rhythm"><div><b><i>SOX2</i></b> variants observed with: hypogonadotropic hypogonadism; anterior pituitary hypoplasia; bilateral anophthalmia/microphthalmia; abnormal corpus callosum; learning difficulties; esophageal atresia; and/or sensorineural hearing loss (See <a href="/books/n/gene/sox2/"><i>SOX2</i>-Related Eye Disorders</a>.)</div></li><li class="half_rhythm"><div><b><i>SOX3</i></b> variants observed with: <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> anterior pituitary hypoplasia with IGHD or panhypopituitarism; infundibular hypoplasia and/or ectopic posterior pituitary; intellectual disability [<a class="bk_pop" href="#prop1.REF.solomon.2004.669">Solomon et al 2004</a>, <a class="bk_pop" href="#prop1.REF.woods.2005.833">Woods et al 2005</a>]</div></li><li class="half_rhythm"><div><b><i>OTX2</i></b> variants observed with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> growth hormone deficiency (IGHD) with small anterior pituitary gland, invisible stalk, ectopic posterior lobe, and anophthalmia [<a class="bk_pop" href="#prop1.REF.diaczok.2008.4351">Diaczok et al 2008</a>]</div></li><li class="half_rhythm"><div><b><i>GLI2</i></b> variants observed with <a href="/books/n/gene/hpe-overview/">holoprosencephaly</a>, abnormal pituitary gland function, and variable craniofacial abnormalities. Other features included postaxial polydactyly, single nares, single central incisor, and partial agenesis of the corpus callosum [<a class="bk_pop" href="#prop1.REF.roessler.2003.13424">Roessler et al 2003</a>].</div></li></ul></div></div><div id="prop1.Management"><h2 id="_prop1_Management_">Management</h2><div id="prop1.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in each individual with newly diagnosed <i>PROP1</i>-related combined pituitary hormone deficiency (CPHD), it is important to evaluate for deficiencies of GH, TSH, LH, FSH, PRL, and ACTH because treatment of one hormone deficiency can precipitate symptoms of another hormone deficiency:</p><ul><li class="half_rhythm"><div>A total T<sub>4</sub> assay can be used to evaluate thyroid hormone production.</div></li><li class="half_rhythm"><div>Evaluation of LH and FSH production is more relevant in postpubertal individuals, particularly if sexual development is incomplete or if women display hypoestrogenic amenorrhea.</div></li><li class="half_rhythm"><div>AM cortisol can be used to evaluate adrenal hormone production.</div></li></ul><p>Consultation with a clinical geneticist and/or genetic counselor is appropriate.</p></div><div id="prop1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The main principle of treatment in CPHD is replacement therapy with the appropriate hormones [<a class="bk_pop" href="#prop1.REF.mehta.2009">Mehta et al 2009</a>].</p><p><b>Growth hormone.</b> GH deficiency is treated by subcutaneous injection of biosynthetic (i.e., recombinant) GH. To obtain an optimal outcome, replacement therapy should be started as soon as the diagnosis of GH deficiency is established. The initial dose of recombinant human GH (rhGH) is based on body weight, but the exact dose and the frequency of administration vary by protocol. The dose increases with increasing body weight to a maximum during puberty and is usually discontinued when final height has been reached, at approximately age 17 years [<a class="bk_pop" href="#prop1.REF.ranke.1995.122">Ranke 1995</a>, <a class="bk_pop" href="#prop1.REF.ros_n.1995.93">Ros&#x000e9;n et al 1995</a>, <a class="bk_pop" href="#prop1.REF1">Growth Hormone Research Society 2000</a>] (<a href="http://jcem.endojournals.org/content/85/11/3990.long" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p>There is increasing support for the use of rhGH treatment in young adults with GHD as well because of the possible effects on fat metabolism, lean body mass, and bone mineral density [<a class="bk_pop" href="#prop1.REF.ho.2007.695">Ho et al 2007</a>] (<a href="http://www.ghresearchsociety.org/files/2007_Consensus_AGHD.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p>Clinical response to exogenous GH usually depends on the etiology and severity of the GH deficiency, deficiencies of other pituitary hormones, age of onset of growth failure, the time interval between the onset of growth failure and the onset of GH therapy, duration of replacement therapy, and the sex of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#prop1.REF.blethen.1997.418">Blethen et al 1997</a>]. <a class="bk_pop" href="#prop1.REF.de_ridder.2007.925">De Ridder et al [2007]</a> developed a model that accurately predicts the adult height that will be achieved by GH therapy.</p><p><b>TSH.</b> TSH deficiency is treated by thyroid hormone replacement in the form of L-thyroxine at a dose of approximately 1-3 &#x000b5;g/kg/day given orally. Of note, thyroid hormone replacement should not be initiated until adrenal function has been assessed and adrenal insufficiency is treated if present.</p><p><b>LH and FSH</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Male infants with micropenis are treated with 50 mg testosterone enanthate intramuscularly every four weeks for a total of three to four doses.</div></li><li class="half_rhythm"><div class="half_rhythm">If GH deficiency is present and if the child's growth normalizes before adolescence, it is appropriate to begin sex steroid replacement to induce secondary sex characteristics.</div><ul><li class="half_rhythm"><div>In males, this can be initiated at age 12 to 13 years with monthly injections of 100 mg testosterone enanthate, gradually increasing by 50 mg every six months to a dose of 200 to 300 mg per month.</div></li><li class="half_rhythm"><div>In females, this can be initiated at age 11 to 12 years with conjugated estrogens or ethinyl estradiol, eventually cycling with estrogen and progesterone.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">If the child has untreated growth hormone deficiency, the sex hormone replacement is given in lower doses and started at a later age to ensure maximal growth before epiphyseal closure.</div></li><li class="half_rhythm"><div class="half_rhythm">Usually sex steroids are used to maintain secondary sex characteristics.</div></li><li class="half_rhythm"><div class="half_rhythm">Fertility in both females and males is possible with administration of gonadotropins [<a class="bk_pop" href="#prop1.REF.voutetakis.2004c.454">Voutetakis et al 2004c</a>].</div><div class="half_rhythm">Note: Because infertility in individuals with <i>PROP1</i>-related CPHD is secondary to hypogonadotropic hypogonadism, appropriate treatment consists of gonadotropin replacement rather than the use of clomiphene citrate, which requires an intact pituitary gland.</div></li></ul><p><b>ACTH.</b> Long-term management is usually 10-15 mg/M<sup>2</sup> oral hydrocortisone per 24 hours divided into three doses.</p><ul><li class="half_rhythm"><div>For individuals with GH deficiency, the lowest safe dose of hydrocortisone is used to avoid interfering with the growth response to growth hormone therapy.</div></li><li class="half_rhythm"><div>For minor stress such as fever or minor illness, the dose of hydrocortisone is doubled or tripled until the illness has resolved.</div></li><li class="half_rhythm"><div>For major stress, such as surgery or significant illness, hydrocortisone is increased to 40 to 100 mg/M<sup>2</sup> and administered parenterally.</div></li></ul></div><div id="prop1.Surveillance"><h3>Surveillance</h3><p>Growth should be carefully monitored; if growth velocity is low, evaluation for GH deficiency should be undertaken.</p><p>In persons with <i>PROP1</i> pathogenic variants without known ACTH deficiency, cortisol levels should be monitored because ACTH deficiency may develop at a later time.</p></div><div id="prop1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>If both (paternal and maternal) <i>PROP1</i> pathogenic variants are identified in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, it is appropriate to perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> on younger sibs to enable early diagnosis and treatment.</p><p>For younger sibs who have not undergone <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, monitoring growth for evidence of growth failure is appropriate. Of note, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs usually have extreme short stature because of thyroid hormone deficiency and growth hormone deficiency.</p><p>See <a href="#prop1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="prop1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="prop1.Genetic_Counseling"><h2 id="_prop1_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="prop1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>PROP1</i>-related combined pituitary hormone deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="prop1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>).</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the chance of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Fertility is reduced in individuals with <i>PROP1</i>-related CPHD.</div></li><li class="half_rhythm"><div>If an individual with <i>PROP1</i>-related CPHD were fertile, each offspring would be an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PROP1</i>.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="prop1.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing is possible if the <i>PROP1</i> pathogenic variants have been identified in the family.</p></div><div id="prop1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#prop1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="prop1.Prenatal_Testing_and_Primplantatio"><h3>Prenatal Testing and Primplantation Genetic Diagnosis</h3><p>Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="prop1.Resources"><h2 id="_prop1_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Human Growth Foundation (HGF)</b></div><div>997 Glen Cove Avenue</div><div>Suite 5</div><div>Glen Head NY 11545</div><div><b>Phone:</b> 800-451-6434 (toll-free)</div><div><b>Fax:</b> 516-671-4055</div><div><b>Email:</b> hgf1@hgfound.org</div><div><a href="http://www.hgfound.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hgfound.org</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li></ul></div><div id="prop1.Molecular_Genetics"><h2 id="_prop1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="prop1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>PROP1-Related Combined Pituitary Hormone Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1347/table/prop1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prop1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_prop1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_prop1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_prop1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_prop1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_prop1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_prop1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_prop1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5626" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PROP1</i></a></td><td headers="hd_b_prop1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5626" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q35<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_prop1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75360" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Homeobox protein prophet of Pit-1</a></td><td headers="hd_b_prop1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PROP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROP1 database</a></td><td headers="hd_b_prop1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PROP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROP1</a></td><td headers="hd_b_prop1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PROP1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROP1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="prop1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="prop1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for PROP1-Related Combined Pituitary Hormone Deficiency (<a href="/omim/262600,601538" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1347/table/prop1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prop1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/262600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">262600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601538" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601538</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROP PAIRED-LIKE HOMEOBOX 1; PROP1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PROP1</i> comprises three exons of 418, 233, and 339 bp and spans 3.54 kb. Transcripts are 1464 nucleotides long. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1347/#prop1.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants</b> (see <a class="figpopup" href="/books/NBK1347/table/prop1.T.selected_prop1_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figprop1Tselectedprop1pathogenicvarian" rid-ob="figobprop1Tselectedprop1pathogenicvarian">Table 3</a>)</p><ul><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.wu.1998.147">Wu et al [1998]</a> reported five families in which CPHD was caused by homozygosity or compound heterozygosity for <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> variants of <i>PROP1</i>; these variants result in <i>PROP1</i> products with reduced DNA binding and transcriptional activation. The variant c.301_302delAG was detected on different haplotypes in families with CPHD from different countries. These data strongly suggest that the c.301_302delAG is a recurrent variant, possible resulting from DNA slippage repair defects.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.paracchini.2003.142">Paracchini et al [2003]</a> described two sibs with compound heterozygosity p.[Arg71Cys]+[Arg71His] in the first alpha helix of the <i>PROP1</i> homeodomain (no in vitro analysis was performed). Both had GH and TSH deficiency and short stature. One sib, who was of pubertal age, lacked breast development.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.reynaud.2004.5779">Reynaud et al [2004]</a> described a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> c.217C&#x0003e;T variant in a large, <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> kindred. All 12 individuals studied had complete GH deficiency. Eleven of 12 had TSH deficiency and eight of ten had ACTH deficiency. Only two females had spontaneous puberty. In vitro studies revealed that the mutated protein had 11.5% of transactivation capacity of wild type <i>PROP1</i> and was unable to bind a high-affinity DNA sequence.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.tatsumi.2004.635">Tatsumi et al [2004]</a> reported the first instance of <i>PROP1</i> variants causing CPHD in Japanese individuals. Two sibs presenting with early-onset growth deficiency and deficiencies of GH, TSH, PRL, and gonadotropins were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for c.157delA. The protein, if translated, predicts the absence of the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.voutetakis.2004b.257">Voutetakis et al [2004b]</a> reported compound heterozygosity for p.Leu102CysfsTer8 (c.300_301 delGA) and a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant p.Gln83Ter (in a neonate with jaundice and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypothyroidism.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.voutetakis.2004a.2200">Voutetakis et al [2004a]</a> reported 15 individuals (age 2.5-45 years) with a variety of different <i>PROP1</i> genotypes including:</div><ul><li class="half_rhythm"><div>Homozygosity for c.300_301delGA (7 individuals);</div></li><li class="half_rhythm"><div>Homozygosity for c.150delA (5 individuals);</div></li><li class="half_rhythm"><div>Compound heterozygosity for c.[300_301delGA]+[150delA] (2 individuals);</div></li><li class="half_rhythm"><div>Compound heterozygosity for c.[300_301delGA]+[218G&#x0003e;A] (1 individual).</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.b_ttner.2004.5256">B&#x000f6;ttner et al [2004]</a> reported a progressive decline with age in peak levels of GH, TSH, prolactin, and LH/FSH in nine individuals with the variants c.300_301delGA, c.150delA, and/or c.109+1G&#x0003e;T. Although mutation of <i>PROP1</i> is usually not associated with ACTH deficiency, all patients developed at least partial adrenal insufficiency, with a gradual decline of the function of the pituitary adrenal axis, and eventually required treatment with hydrocortisone.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.reynaud.2005.4880">Reynaud et al [2005]</a> reported three brothers with hypogonadotropic hypogonadism as a result of homozygosity for the <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant c.582G&#x0003e;A (p.Trp194Ter) causing premature truncation of the protein in the transactivation <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. The brothers reached normal adult height but developed GH and TSH deficiencies after age 30 years. In vitro studies revealed that the transactivation capacity of the protein was 34.4% of wild type and suggested that the C-terminal end of the protein plays a role in protein-DNA binding.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.turton.2005.10">Turton et al [2005]</a> described considerable phenotypic variability in sibs with CPHD, suggesting that modifying environmental or genetic factors play a role in phenotypic expression of disease. In addition, they report the variant c.112_124del as a possible <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> from the Indian subcontinent, having identified the variant in eight individuals from five different families.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.nose.2006.491">Nose et al [2006]</a> described an <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>, c.467_468insT, located in the transcription-activating region of <i>PROP1</i> in two sisters with slight pituitary hypoplasia and deficiencies of growth hormone, thyroid stimulating hormone, prolactin, and gonadotropins; adrenocorticotropin secretion appeared adequate.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.lemos.2006.479">Lemos et al [2006]</a> described a novel initiation codon variant (c.2T&#x0003e;C), the first variant reported in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1, which appears to lead to a <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> that abolishes the translation of the PROP1 protein.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.abr_o.2006.294">Abr&#x000e3;o et al [2006]</a> reported complete <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>PROP1</i> in two sibs with GH deficiency associated with other pituitary hormone deficiencies (TSH, PRL, and gonadotropins). One of the sibs also had an evolving cortisol deficiency.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.kelberman.2009.96">Kelberman et al [2009]</a> reported compound heterozygosity for the c.373C&#x0003e;T and c.310delC variants associated with CPHD including ACTH deficiency. Two individuals harboring a complete <i>PROP1</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> had normal cortisol secretion.</div><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.kelberman.2009.96">Kelberman et al [2009]</a> also reported an <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> c.343-11C&#x0003e;G variant associated with CPHD, which disrupts correct <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> resulting in the loss of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 from the <i>PROP1</i> transcript.</div></li><li class="half_rhythm"><div class="half_rhythm"><a class="bk_pop" href="#prop1.REF.zhang.2010.98">Zhang et al [2010]</a> reported a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of a segment of about 53.2 kb encompassing <i>PROP1</i> and adjacent sequences in two pedigrees with CPHD.</div></li></ul><p>No <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>PROP1</i> variants have been reported to date. (For more information see <a href="/books/NBK1347/#prop1.molgen.TA">Table A</a>.)</p><div id="prop1.T.selected_prop1_pathogenic_varian" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>PROP1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1347/table/prop1.T.selected_prop1_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prop1.T.selected_prop1_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2T&#x0003e;C</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(<a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>)</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_3" rowspan="17" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_006261.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006261<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_006252.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006252<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.109+1G&#x0003e;T<br />(IVS1+1G&#x0003e;T)</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.112_124del</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser38ProfsTer123</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.150delA</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg53AspfsTer112</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.157delA</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg53AspfsTer112</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.211C&#x0003e;T</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg71Cys</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.212G&#x0003e;A</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg71His</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.217C&#x0003e;T</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg73Cys</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.218G&#x0003e;A</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg73His</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.247C&#x0003e;T</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln83Ter</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.300_301delGA<br />(GA296deletion)</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu102CysfsTer8</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.301_302delAG</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu102CysfsTer8</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.310delC</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg104GlyfsTer61</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.343-11C&#x0003e;G</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.373C&#x0003e;T</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg125Trp</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.467_468insT<br />(467insT)</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr157LeufsTer36</td></tr><tr><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.582G&#x0003e;A</td><td headers="hd_h_prop1.T.selected_prop1_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp194Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="prop1.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The product of <i>PROP1,</i> homeobox protein prophet of PIT-1, has DNA-binding and transcriptional activation ability. Expression of homeobox protein prophet of PIT-1 is required for the ontogenesis of pituitary gonadotropes, somatotropes, lactotropes, and thyrotropes needed for the normal production of FSH, LH, GH, PrL, and TSH. Two conserved basic regions within the homeodomain are important for localization to the nucleus, DNA binding, and target gene activation. Missense variants in these two regions of <i>PROP1</i> result in CPHD, indicating the importance of these conserved sequences [<a class="bk_pop" href="#prop1.REF.guy.2004.263">Guy et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Products of mutated <i>PROP1</i> alleles have reduced or absent DNA-binding and transcriptional activation ability.</p></div><div id="prop1.References"><h2 id="_prop1_References_">References</h2><div id="prop1.Published_Guidelines__Consensus_St"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="prop1.REF1">Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. Available <a href="http://jcem.endojournals.org/content/85/11/3990.long" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2000. Accessed 10-22-19. [<a href="/pubmed/11095419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11095419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.ho.2007">Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Available <a href="http://www.ghresearchsociety.org/files/2007_Consensus_AGHD.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2007. Accessed 10-22-19. [<a href="/pubmed/18057375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18057375</span></a>]</div></li></ul></div><div id="prop1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.aarskog.1997.829">Aarskog D, Eiken HG, Bjerknes R, Myking OL. Pituitary dwarfism in the R271W Pit-1 gene mutation. <span><span class="ref-journal">Eur J Pediatr. </span>1997;<span class="ref-vol">156</span>:829–34.</span> [<a href="/pubmed/9392392" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9392392</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.abr_o.2006.294">Abr&#x000e3;o MG, Leite MV, Carvalho LR, Billerbeck AE, Nishi MY, Barbosa AS, Martin RM, Arnhold IJ, Mendonca BB. Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2006;<span class="ref-vol">65</span>:294–300.</span> [<a href="/pubmed/16918947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16918947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.ashkenazihoffnung.2010.721">Ashkenazi-Hoffnung L, Lebenthal Y, Wyatt AW, Ragge NK, Dateki S, Fukami M, Ogata T, Phillip M, Gat-Yablonski G. A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency. <span><span class="ref-journal">Hum Genet. </span>2010;<span class="ref-vol">127</span>:721–9.</span> [<a href="/pubmed/20396904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20396904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.blethen.1997.418">Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1997;<span class="ref-vol">82</span>:418–20.</span> [<a href="/pubmed/9024229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9024229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.b_ttner.2004.5256">B&#x000f6;ttner A, Keller E, Kratzsch J, Stobbe H, Weigel JF, Keller A, Hirsch W, Kiess W, Blum WF, Pf&#x000e4;ffle RW. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2004;<span class="ref-vol">89</span>:5256–65.</span> [<a href="/pubmed/15472232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15472232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.cohen.2003.4832">Cohen RN, Cohen LE, Botero D, Yu C, Sagar A, Jurkiewicz M, Radovick S. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2003;<span class="ref-vol">88</span>:4832–9.</span> [<a href="/pubmed/14557462" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14557462</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.dateki.2010.4043">Dateki S, Fukami M, Uematsu A, Kaji M, Iso M, Ono M, Mizota M, Yokoya S, Motomura K, Kinoshita E, Moriuchi H, Ogata T. Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2010;<span class="ref-vol">95</span>:4043–7.</span> [<a href="/pubmed/20534763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20534763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.dattani.2003">Dattani MT (2003) DNA testing in patients with GH deficiency at the time of transition. Growth Horm IGF Res. 13 Suppl A:S122-9. [<a href="/pubmed/12914740" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12914740</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.dattani.1998.125">Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">19</span>:125–33.</span> [<a href="/pubmed/9620767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9620767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.de_graaff.2010.363">de Graaff LC, Argente J, Veenma DC, Drent ML, Uitterlinden AG, Hokken-Koelega AC. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. <span><span class="ref-journal">Horm Res Paediatr. </span>2010;<span class="ref-vol">73</span>:363–71.</span> [<a href="/pubmed/20389107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20389107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.de_ridder.2007.925">de Ridder MA, Stijnen T, Hokken-Koelega AC. Prediction of adult height in growth-hormone-treated children with growth hormone deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2007;<span class="ref-vol">92</span>:925–31.</span> [<a href="/pubmed/17179199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17179199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.delado_y.1999.1645">Delado&#x000eb;y J, Fl&#x000fc;ck C, B&#x000fc;y&#x000fc;kgebiz A, Kuhlmann BV, Ebl&#x000e9; A, Hindmarsh PC, Wu W, Mullis PE. "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1999;<span class="ref-vol">84</span>:1645–50.</span> [<a href="/pubmed/10323394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10323394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.diaczok.2008.4351">Diaczok D, Romero C, Zunich J, Marshall I, Radovick S. A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2008;<span class="ref-vol">93</span>:4351–9.</span> [<a href="/pmc/articles/PMC2582563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2582563</span></a>] [<a href="/pubmed/18728160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18728160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.fernandezrodriguez.2011.181">Fernandez-Rodriguez E, Quinteiro C, Barreiro J, Marazuela M, Pereiro I, Pein&#x000f3; R, Cabezas-Agr&#x000ed;cola JM, Dominguez F, Casanueva FF, Bernabeu I. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis. <span><span class="ref-journal">Neuroendocrinology. </span>2011;<span class="ref-vol">93</span>:181–8.</span> [<a href="/pubmed/21304225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21304225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.fl_ck.1998.3727">Fl&#x000fc;ck C, Deladoey J, Rutishauser K, Ebl&#x000e9; A, Marti U, Wu W, Mullis PE. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg--&#x0003e;Cys at codon 120 (R120C). <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1998;<span class="ref-vol">83</span>:3727–34.</span> [<a href="/pubmed/9768691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9768691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.fofanova.1998.45">Fofanova OV, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S. A mutational hot spot in the Prop-1 gene in Russian children with combined pituitary hormone deficiency. <span><span class="ref-journal">Pituitary. </span>1998;<span class="ref-vol">1</span>:45–9.</span> [<a href="/pubmed/11081182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11081182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.growth_hormone_research_society.2000.3990">Growth Hormone Research Society.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2000;<span class="ref-vol">85</span>:3990–3.</span> [<a href="/pubmed/11095419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11095419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.guy.2004.263">Guy JC, Hunter CS, Showalter AD, Smith TP, Charoonpatrapong K, Sloop KW, Bidwell JP, Rhodes SJ. Conserved amino acid sequences confer nuclear localization upon the Prophet of Pit-1 pituitary transcription factor protein. <span><span class="ref-journal">Gene. </span>2004;<span class="ref-vol">336</span>:263–73.</span> [<a href="/pubmed/15246537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15246537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.hal_sz.2006.255">Hal&#x000e1;sz Z, Toke J, Pat&#x000f3;cs A, Bertalan R, T&#x000f6;mb&#x000f6;l Z, Sallai A, Hossz&#x000fa; E, Muzsnai A, Kov&#x000e1;cs L, S&#x000f3;lyom J, Fekete G, R&#x000e1;cz K. High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency. <span><span class="ref-journal">Endocrine. </span>2006;<span class="ref-vol">30</span>:255–60.</span> [<a href="/pubmed/17526936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17526936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.ho.2007.695">Ho KK, et al.  Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. <span><span class="ref-journal">Eur J Endocrinol. </span>2007;<span class="ref-vol">157</span>:695–700.</span> [<a href="/pubmed/18057375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18057375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.kelberman.2007.s3">Kelberman D, Dattani MT. Hypothalamic and pituitary development: novel insights into the aetiology. <span><span class="ref-journal">Eur J Endocrinol. </span>2007;<span class="ref-vol">157</span> Suppl 1:S3–14.</span> [<a href="/pubmed/17785694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17785694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.kelberman.2009.96">Kelberman D, Turton JP, Woods KS, Mehta A, Al-Khawari M, Greening J, Swift PG, Otonkoski T, Rhodes SJ, Dattani MT. Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD). <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2009;<span class="ref-vol">70</span>:96–103.</span> [<a href="/pubmed/19128366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19128366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.kim.2003.277">Kim SS, Kim Y, Shin YL, Kim GH, Kim TU, Yoo HW. Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging. <span><span class="ref-journal">Horm Res. </span>2003;<span class="ref-vol">60</span>:277–83.</span> [<a href="/pubmed/14646405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14646405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.lebl.2005.389">Lebl J, Vos&#x000e1;hlo J, Pfaeffle RW, Stobbe H, Cern&#x000e1; J, Novotn&#x000e1; D, Zapletalov&#x000e1; J, Kalvachov&#x000e1; B, H&#x000e1;na V, Weiss V, Blum WF. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. <span><span class="ref-journal">Eur J Endocrinol. </span>2005;<span class="ref-vol">153</span>:389–96.</span> [<a href="/pubmed/16131601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16131601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.lemos.2006.479">Lemos MC, Gomes L, Bastos M, Leite V, Limbert E, Carvalho D, Bacelar C, Monteiro M, Fonseca F, Agapito A, Castro JJ, Regateiro FJ, Carvalheiro M. PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2006;<span class="ref-vol">65</span>:479–85.</span> [<a href="/pubmed/16984240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16984240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.mclennan.2003.785">McLennan K, Jeske Y, Cotterill A, Cowley D, Penfold J, Jones T, Howard N, Thomsett M, Choong C. Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2003;<span class="ref-vol">58</span>:785–94.</span> [<a href="/pubmed/12780757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12780757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.mcnay.2007.691">McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, Keller E, Keller A, Haufs N, Krude H, Shalet SM, Dattani MT. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2007;<span class="ref-vol">92</span>:691–7.</span> [<a href="/pubmed/17148560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17148560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.mehta.2009">Mehta A, Gevers EF, Dattani MT. Congenital disorders of the hypothalamo-pituitary-somatotrope axis. In: Brook CDG, Clayton PE, Brown RS, eds. <em>Brook&#x02019;s Clinical Pediatric Endocrinology</em>. 6 ed. Boston, MA: Wiley-Blackwell; 2009:60-104.</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.mendonca.1999.942">Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1999;<span class="ref-vol">84</span>:942–5.</span> [<a href="/pubmed/10084575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10084575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.navardauskaite.2014.299">Navardauskaite R, Dusatkova P, Obermannova B, Pfaeffle RW, Blum WF, Adukauskiene D, Smetanina N, Cinek O, Verkauskiene R, Lebl J. High prevalence of PROP1 defects in Lithuania: phenotypic findings in an ethnically homogenous cohort of patients with multiple pituitary hormone deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2014;<span class="ref-vol">99</span>:299–306.</span> [<a href="/pubmed/24178788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24178788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.nose.2006.491">Nose O, Tatsumi K, Nakano Y, Amino N. Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT). <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2006;<span class="ref-vol">19</span>:491–8.</span> [<a href="/pubmed/16759034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16759034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.nystr_m.2011.208">Nystr&#x000f6;m HF, Saveanu A, Barbosa EJ, Barlier A, Enjalbert A, Glad C, Palming J, Johannsson G, Brue T. Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency. <span><span class="ref-journal">Pituitary. </span>2011;<span class="ref-vol">14</span>:208–16.</span> [<a href="/pubmed/21132537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21132537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.osorio.2002.5076">Osorio MG, Marui S, Jorge AA, Latronico AC, Lo LS, Leite CC, Estefan V, Mendonca BB, Arnhold IJ. Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2002;<span class="ref-vol">87</span>:5076–84.</span> [<a href="/pubmed/12414875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12414875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.paracchini.2003.142">Paracchini R, Giordano M, Corrias A, Mellone S, Matarazzo P, Bellone J, Momigliano-Richiardi P, Bona G. Two new PROP1 gene mutations responsible for compound pituitary hormone deficiency. <span><span class="ref-journal">Clin Genet. </span>2003;<span class="ref-vol">64</span>:142–7.</span> [<a href="/pubmed/12859410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12859410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.pernasetti.2000.390">Pernasetti F, Toledo SP, Vasilyev VV, Hayashida CY, Cogan JD, Ferrari C, Louren&#x000e7;o DM Jr, Mellon PL. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2000;<span class="ref-vol">85</span>:390–7.</span> [<a href="/pubmed/10634415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10634415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.pf_ffle.2011.43">Pf&#x000e4;ffle R, Klammt J. Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2011;<span class="ref-vol">25</span>:43–60.</span> [<a href="/pubmed/21396574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21396574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.phillips.1995">Phillips JA III. Inherited defects in growth hormone synthesis and action. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <em>The Metabolic Basis of Inherited Disease</em>, 6 ed. New York, NY: McGraw-Hill; 1995:3023-44.</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.pirinen.1994.144">Pirinen S, Majurin A, Lenko HL, Koski K. Craniofacial features in patients with deficient and excessive growth hormone. <span><span class="ref-journal">J Craniofac Genet Dev Biol. </span>1994;<span class="ref-vol">14</span>:144–52.</span> [<a href="/pubmed/7852543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7852543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.rainbow.2005.163">Rainbow LA, Rees SA, Shaikh MG, Shaw NJ, Cole T, Barrett TG, Kirk JM. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2005;<span class="ref-vol">62</span>:163–8.</span> [<a href="/pubmed/15670191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15670191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.ranke.1995.122">Ranke MB. Growth hormone therapy in children: when to stop? <span><span class="ref-journal">Horm Res. </span>1995;<span class="ref-vol">43</span>:122–5.</span> [<a href="/pubmed/7750910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7750910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.reynaud.2005.4880">Reynaud R, Barlier A, Vallette-Kasic S, Saveanu A, Guillet MP, Simonin G, Enjalbert A, Valensi P, Brue T. An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2005;<span class="ref-vol">90</span>:4880–7.</span> [<a href="/pubmed/15941866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15941866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.reynaud.2004.5779">Reynaud R, Chadli-Chaieb M, Vallette-Kasic S, Barlier A, Sarles J, Pellegrini-Bouiller I, Enjalbert A, Chaieb L, Brue T. A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2004;<span class="ref-vol">89</span>:5779–86.</span> [<a href="/pubmed/15531542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15531542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.reynaud.2006.3329">Reynaud R, Gueydan M, Saveanu A, Vallette-Kasic S, Enjalbert A, Brue T, Barlier A. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2006;<span class="ref-vol">91</span>:3329–36.</span> [<a href="/pubmed/16735499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16735499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.riepe.2001.4353">Riepe FG, Partsch CJ, Blankenstein O, Monig H, Pfaffle RW, Sippell WG. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2001;<span class="ref-vol">86</span>:4353–7.</span> [<a href="/pubmed/11549674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11549674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.rimoin.1997">Rimoin DL, Phillips JA III. Genetic disorders of the pituitary gland. In: Rimoin DL, Connor JM, Pyeritz RE, eds. <em>Principles and Practice of Medical Genetics</em>. 3 ed. New York, NY: Churchill Livingstone; 1997:1331-64.</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.roessler.2003.13424">Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz I, Altaba A, Muenke M. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:13424–9.</span> [<a href="/pmc/articles/PMC263830/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC263830</span></a>] [<a href="/pubmed/14581620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14581620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.ros_n.1995.93">Ros&#x000e9;n T, Johannsson G, Johansson JO, Bengtsson BA. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper. <span><span class="ref-journal">Horm Res. </span>1995;<span class="ref-vol">43</span>:93–9.</span> [<a href="/pubmed/7721271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7721271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.rosenfeld.1996">Rosenfeld RG. Disorders of growth hormone and insulin-like growth factor secretion and action. In: Sperling MA, ed. <em>Pediatric Endocrinology</em>. 1 ed. Philadelphia, PA: WB Saunders. 1996:117-70.</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.solomon.2004.669">Solomon NM, Ross SA, Morgan T, Belsky JL, Hol FA, Karnes PS, Hopwood NJ, Myers SE, Tan AS, Warne GL, Forrest SM, Thomas PQ. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:669–78.</span> [<a href="/pmc/articles/PMC1735898/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735898</span></a>] [<a href="/pubmed/15342697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15342697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.tatsumi.2004.635">Tatsumi KI, Kikuchi K, Tsumura K, Amino N. A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2004;<span class="ref-vol">61</span>:635–40.</span> [<a href="/pubmed/15521968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15521968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.turton.2005.10">Turton JP, Mehta A, Raza J, Woods KS, Tiulpakov A, Cassar J, Chong K, Thomas PQ, Eunice M, Ammini AC, Bouloux PM, Starzyk J, Hindmarsh PC, Dattani MT. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2005;<span class="ref-vol">63</span>:10–8.</span> [<a href="/pubmed/15963055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15963055</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.vallettekasic.2001.4529">Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthez&#x000e8;ne F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, Jaquet P, Enjalbert A, Brue T. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2001;<span class="ref-vol">86</span>:4529–35.</span> [<a href="/pubmed/11549703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11549703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.vieira.2007.1097">Vieira TC, Boldarine VT, Abucham J. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. <span><span class="ref-journal">Arq Bras Endocrinol Metabol. </span>2007;<span class="ref-vol">51</span>:1097–103.</span> [<a href="/pubmed/18157385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18157385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.vivenza.2011.705">Vivenza D, Godi M, Faienza MF, Mellone S, Moia S, Rapa A, Petri A, Bellone S, Riccomagno S, Cavallo L, Giordano M, Bona G. A novel HESX1 splice mutation causes isolated GH deficiency by interfering with mRNA processing. <span><span class="ref-journal">Eur J Endocrinol. </span>2011;<span class="ref-vol">164</span>:705–13.</span> [<a href="/pubmed/21325470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21325470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.voutetakis.2004a.2200">Voutetakis A, Argyropoulou M, Sertedaki A, Livadas S, Xekouki P, Maniati-Christidi M, Bossis I, Thalassinos N, Patronas N, Dacou-Voutetakis C. Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2004a;<span class="ref-vol">89</span>:2200–6.</span> [<a href="/pubmed/15126542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15126542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.voutetakis.2004b.257">Voutetakis A, Maniati-Christidi M, Kanaka-Gantenbein C, Dracopoulou M, Argyropoulou M, Livadas S, Dacou-Voutetakis C, Sertedaki A. Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X). <span><span class="ref-journal">Eur J Endocrinol. </span>2004b;<span class="ref-vol">150</span>:257–64.</span> [<a href="/pubmed/15012608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15012608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.voutetakis.2004c.454">Voutetakis A, Sertedaki A, Livadas S, Maniati-Christidi M, Mademtzis I, Bossis I, Dacou-Voutetakis C, Messinis IE. Ovulation induction and successful pregnancy outcome in two patients with Prop1 gene mutations. <span><span class="ref-journal">Fertil Steril. </span>2004c;<span class="ref-vol">82</span>:454–7.</span> [<a href="/pubmed/15302300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15302300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.woods.2005.833">Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Zyoud M, El-Ali M, Otonkoski T, Martinez-Barbera JP, Thomas PQ, Robinson IC, Lovell-Badge R, Woodward KJ, Dattani MT. Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:833–49.</span> [<a href="/pmc/articles/PMC1199372/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1199372</span></a>] [<a href="/pubmed/15800844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15800844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.wu.1998.147">Wu W, Cogan JD, Pf&#x000e4;ffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA 3rd, Rosenfeld MG. Mutations in PROP1 cause familial combined pituitary hormone deficiency. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:147–9.</span> [<a href="/pubmed/9462743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9462743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.zhang.2010.98">Zhang H, Wang Y, Han L, Gu X, Shi D. A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees. <span><span class="ref-journal">Horm Res Paediatr. </span>2010;<span class="ref-vol">74</span>:98–105.</span> [<a href="/pubmed/20395664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20395664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prop1.REF.zimmermann.2007.587">Zimmermann A, Schenk JP, Grigorescu Sido P, Pfaffle R, Lazea C, Zimmermann T, Heinrich U, Weber MM, Bettendorf M. MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2007;<span class="ref-vol">20</span>:587–96.</span> [<a href="/pubmed/17642419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17642419</span></a>]</div></li></ul></div></div><div id="prop1.Chapter_Notes"><h2 id="_prop1_Chapter_Notes_">Chapter Notes</h2><div id="prop1.Author_History"><h3>Author History</h3><p>Laura CG de Graaff, MD, PhD (2011-present)<br />Lawrence C Layman, MD; Medical College of Georgia (1999-2011)<br />John A Phillips III, MD; Vanderbilt University Medical Center (1999-2011)<br />Cindy Vnencak-Jones, PhD; Vanderbilt University Medical Center (1999-2011)</p></div><div id="prop1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 August 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 October 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 November 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 June 2003 (ca) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 December 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>18 October 1999 (jp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1347</span><span class="label">PMID: <a href="/pubmed/20301521" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301521</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/me-ataxia/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/prrt2-parox/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1347&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1347/?report=reader">PubReader</a></li><li><a href="/books/NBK1347/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1347" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1347" style="display:none" title="Cite this Page"><div class="bk_tt">de Graaff LCG. PROP1-Related Combined Pituitary Hormone Deficiency. 2000 Dec 7 [Updated 2014 Aug 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1347/pdf/Bookshelf_NBK1347.pdf">PDF version of this page</a> (522K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#prop1.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#prop1.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#prop1.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#prop1.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#prop1.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#prop1.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#prop1.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#prop1.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#prop1.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#prop1.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#prop1.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5626[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PROP1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1475518" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1475518" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1475518" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1475518" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301509" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balasubramanian R, Crowley WF Jr. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17162714" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Long-term follow-up of combined pituitary hormone deficiency in two siblings with a Prophet of Pit-1 gene mutation.</a><span class="source">[Gynecol Endocrinol. 2006]</span><div class="brieflinkpop offscreen_noflow">Long-term follow-up of combined pituitary hormone deficiency in two siblings with a Prophet of Pit-1 gene mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Georgopoulos NA, Katsikis I, Giamalis P, Koika V, Adonakis G, Kourtis A, Kourounis G, Panidis D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gynecol Endocrinol. 2006 Dec; 22(12):704-9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24354022" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Proopiomelanocortin Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Proopiomelanocortin Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Challis BG, Millington GWM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12812307" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene.</a><span class="source">[Pituitary. 2002]</span><div class="brieflinkpop offscreen_noflow">Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lamesch C, Neumann S, Pfäffle R, Kiess W, Paschke R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pituitary. 2002; 5(3):163-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10634415" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene.</a><span class="source">[J Clin Endocrinol Metab. 2000]</span><div class="brieflinkpop offscreen_noflow">Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pernasetti F, Toledo SP, Vasilyev VV, Hayashida CY, Cogan JD, Ferrari C, Lourenço DM Jr, Mellon PL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Endocrinol Metab. 2000 Jan; 85(1):390-7. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301521" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301521" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d23dde08911694e01b2">PROP1-Related Combined Pituitary Hormone Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">PROP1-Related Combined Pituitary Hormone Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:30:11-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE895A07E040BC510000000000960055&amp;ncbi_session=CE895A07E040D231_0150SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1347%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1347&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1347/&amp;ncbi_pagename=PROP1-Related Combined Pituitary Hormone Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE895A07E040D231_0150SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>